Symphony Environmental Technologies PLC (AIM: SYM) CEO Michael Laurier joined Steve Darling from Proactive with news the company has received U.S. Food & Drugs Administration approval or its d2p antimicrobial technology.
Laurier discusses what that means for the company and what their next steps are including what markets they plan on moving into.
Price: 15 GBX
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Symphony Environmental Technologies PLC named herein, including the promotion by the Company of Symphony Environmental Technologies PLC in any...
FOR OUR FULL DISCLAIMER CLICK HERE
FTSE 100 opened sharply lower as Britain found itself in near isolation due to concern over the new strain of coronavirus in southern England. The blue-chip index dropped 67 to 6,462. Ports have been closed because of the new outbreak with lorries ‘stacked’ up on the road to Dover due to a...
Basic Materials
Health
Retail & consumer
